IGIrmak Guzel

Irmak Guzel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irmak Guzel has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic and Phylogenetic Dissection of SARS‐CoV‐2 Transmission Networks in Healthcare Workers

    by Irmak Güzel, Ayça Arzu Sayıner, Özgür Appak, Ayşe Banu Demir, Ahmet Naci Emecen, Gül Ergör, Belgin Ünal, Oya Özlem Eren-Kutsoylu, Kemal Can Tertemiz, Yusuf Hakan Abacıoğlu

    Understanding how SARS‐CoV‐2 circulates among healthcare workers (HCWs) is critical for maintaining safe hospitals and protecting communities. We retrospectively examined 93 archived nasopharyngeal swabs collected from SARS‐CoV‐2 positive HCWs and their close contacts at a Turkish university hospital between March 2020 and November 2021. Viral RNA was confirmed by RT‐PCR and sequenced with the QIAseq DIRECT SARS‐CoV‐2 workflow on an Illumina platform; genomes were aligned to the Wuhan‐H1 reference and analyzed with maximum‐likelihood phylogenetics. Sixty‐three individuals formed 20 epidemiologically defined clusters (40 HCWs, 23 contacts; mean age ≈ 34 years), most experiencing only mild or moderate illness. Sequencing quality improved as RT‐PCR cycle threshold values fell, and nearly 98% of each genome was covered at 10 × depth. Fourteen viral lineages were detected, yet samples from the same cluster differed by no more than two single‐nucleotide changes, indicating recent person‐to‐person spread. Phylogenetic reconstruction suggested single‐source introduction in three‐quarters of clusters, with the remainder reflecting multiple introductions. Observational data linked transmission events to inconsistent use of personal protective equipment and inadequate physical distancing in break rooms, shared offices, and household settings. By combining genomic and field evidence, this study clarifies the paths by which SARS‐CoV‐2 moved through a healthcare workforce, highlights the value of whole‐genome sequencing for outbreak resolution, and reinforces the continuing need for rigorous infection‐control practices even when overall case severity appears low to prevent future clusters and maintain healthcare resilience.

  • Open Access

    Candida Parapsilosis: a Rare Culprit of Shunt Infection in an Adult

    by Ersin Ikizoglu, Mert Arslan, Irmak Guzel, Ceren Kizmazoglu, Vildan Avkan Oguz, Burak Sade

    Candida parapsilosis is an exceedingly rare cause of ventriculoperitoneal (VP) shunt infection, even in patients who have a history of long‐term antibiotic use, immune‐compromised newborns, and intensive care unit patients. We hereby report a case of a 53‐year‐old male who presented with subarachnoid hemorrhage and had a complicated postoperative course due to C. parapsilosis infection, and we discuss the pertinent clinical aspects.

  • Open Access

    Neutralizing Antibody Dynamics and Correlation with Anti-RBD IgG Levels after CoronaVac Vaccine and Booster Immunization in Healthcare Workers

    by Irmak Guzel, Gamze Öztürk, Ozgur Appak, Derya Çağlayan, Ahmet Furkan Süner, Çağlar Irmak, Neslişah ŞİYVE, Elif Işik, Muammer Çeli̇k, Gül Ergör, et al.

    Introduction: Vaccine-induced neutralizing-antibodies(NAbs) are key forCOVID-19 protective-immunity. This study aimed to assess Nabs-dynamics during nine-month follow-up-period after primary-CoronaVac vaccination and booster-immunization and its correlation with anti-RBD-IgG-levels to evaluate vaccination-strategies. Material and Method: This prospective-cohort-study followed 226-healthcare-workers who received double-dose CoronaVac at a university-hospital. Serum samples were collected at four-different-time points after primary and booster(CoronaVac-BNT162b2) immunization. Antibody-levels were assessed by SARS-CoV-2-IgG-II-QUANT(Abbott, USA) and ACE2-RBD-Neutralization-Assay(Dia-Pro, Italy)tests. Factors affecting antibody-response were analyzed. Statistical analysis was performed with IBM-SPSS-22.0. Results: NAbs were detected in 79.2% of participants one-month after the second-dose of CoronaVac but decreased to 48.8% by the fourth-month and was influenced by smoking,BMI and the presence of chronic-diseases. Boosters,regardless of type, significantly raised Nab-levels. Heterologous-vaccination yielded higher NAb and anti-RBD-IgG responses. Single or double-BNT162b2 boosters resulted in similar NAb responses. A strong-correlation was found between anti-RBD-IgG response and Nabs-levels following CoronaVac-vaccination, leading to the determination of predictive IgG-thresholds for the presence-of Nab. The type of-booster influenced the correlation strength and threshold-value. Conclusion: Nabs-levels drop rapidly after primary double-dose CoronaVac-vaccination. Booster-doses significantly increase these levels while the combination of heterologous-vaccines ensures a higher-response. Anti-RBD-IgG levels can predict NAb response however the correlation varies by the type of-vaccine, the strength of the resulting Nab response and the time-since-vaccination.

  • Pre-infection antibody levels of vaccinated healthcare workers with SARS-CoV-2 breakthrough infection: A nested case-control study

    by Sema Alp Çavuş, Muammer Çelik, Ahmet Furkan Süner, Irmak Güzel, Çağlar Irmak, Derya Çağlayan, Huriye Gamze Öztürk, Neslişah Şiyve, Özgür Appak, Elif Işık, et al.